Over the past few years, the landscape of mRNA technology and drug delivery has witnessed transformative evolution, marked by groundbreaking developments in mRNA vaccine design, therapeutic applications, analytics, and manufacturing. CHI’s mRNA Manufacturing and Delivery Stream will serve as an incubator of ideas, fostering collaboration and discussion on the latest trends in mRNA vaccine design, analytics, and scalable manufacturing. Additionally, experts will share formulation and delivery strategies for mRNAs, proteins, novel modalities therapies, and non-traditional modalities through case studies, unpublished work, and winning strategies.
Conferences Include:
mRNA Development, Analytics and Manufacturing
Formulation and Delivery of High-Concentration Proteins and New Modalities
Keynote Presentations Include:
What We Know and Do Not Know about Analytical Testing for mRNA Characterization
Jianmei D. Kochling, PhD, Senior Director, Head of Analytical Development and QC, mRNA Center of Excellence, Sanofi
Applying Deep Learning to Predict High-Concentration Antibody Viscosity
Pin-Kuang Lai, PhD, Assistant Professor, Department of Chemical Engineering and Materials Science, Stevens Institute of Technology
Featured Presentation Includes:
DNA Starting Material Quality: A Copy Can Only Be As Good As The Template
Lawrence C. Thompson, PhD, Senior Principal Scientist, Analytical R&D, Pfizer Inc.
Concentrating siRNA by Ultrafiltration for Gene Therapy Applications
Ken K. Qian, PhD, Scientific Director, Eli Lilly & Co.